Skip to main content
. 2000 Jul;157(1):257–266. doi: 10.1016/S0002-9440(10)64536-1

Table 1.

Comparative Genomic Hybridization of Type A Thymoma (Medullary Thymoma), Type B3 Thymoma (Well-Differentiated Thymic Carcinoma), and Primary Thymic Squamous Cell Carcinoma: Patient Data and Chromosomal Gains and Losses Detected by CGH

Case Age Sex WHO Type Stage MG rev ish enh rev ish dim
1 65 m A I ng
2 66 m A I yes
3 74 f A I ng
4 60 f A I no
5 73 f A II no
6 57 f A I ng
7 68 m A III no
8 74 m A II yes −6p21-pter
9 65 m A I no
10 71 m A I ng
11 47 m A III no
12 57 m A I no
13 46 m B3 IVb yes +1q −6
48 m B3 R IVb yes +1q,+5p,+5cen-q21, +Xq22-qter −6
14 45 m B3 III yes +1q22-qter, +Xq24-qter −13q21-q31
15 63 f B3 II ng +17q
16 65 m B3 IVb yes +16
17 73 f B3 II yes +1q −6
18 42 f B3 ng yes +1q
19 46 f B3 III yes +1q, ampl 8p12 −6,−18q
20 63 m B3 IVb ng +1q,+7
21 29 m B3 II yes −13q
22 42 f B3 II yes +1q −6
23 53 f B3 III ng −13q21-qter
24 61 m B3 ng ng +1q −6
25 47 f B3 II yes +1q23-qter
26 63 m B3 IV no +8,+Xq21-qter −13q
27 57 m B3 II yes +1q −6q,−12p, −12cen-12q21
28 63 m B3 III yes +1q −3p, −3q13,−13q14-qter,−16q12-q21
29 ng f C(TSSC) ng ng +5p,+8q −3p13-pter, −8p,−5q15-q23
30 57 f C(TSSC) III ng −3
61 f C(TSSC) R IVa ng −3
31 57 f C(TSSC) ng ng −6,−16q
32 45 m C(TSSC) III no +1q,+17q, +18q23 −16q21-qter,−17p13
33 67 m C(TSSC) III no +1q, +3q21-q22 −2q32-q33,−3p,−9,−13cen-q31,−16q,−17p13
34 63 m C(TSSC) II no +1q,+5,+18 −6,−13q, −16q
35 43 m C(TSSC) ng no −16q
36 64 f C(TSSC) III no +1q,+8,+17q,+18 −6, −16q,−17p
37 72 f C(TSSC) ng no +1q,+5q33, +14q22-qter,+15,+17q −6q

Abbreviations: m, male; f, female; WHO type, type of thymoma according to the WHO classification 1 ; TSSC, primary thymic squamous cell carcinoma; R, recurrent tumor; stage, stage of thymoma according to Masaoka 28 ; MG, myasthenia gravis; ng, not given; rev ish enh, chromosomal gains detected by CGH; rev ish dim, chromosomal losses detected by CGH.